PHYTOME RESEARCH LIMITED

Company Registration Number:
11394953 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

PHYTOME RESEARCH LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

PHYTOME RESEARCH LIMITED

Balance sheet

As at 31 December 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 204,486 204,486
Tangible assets: 4 5,450,252 4,674,411
Investments: 5 1 0
Total fixed assets: 5,654,739 4,878,897
Current assets
Stocks: 0 2,515
Debtors: 6 437,441 289,707
Cash at bank and in hand: 196,913 33,761
Investments:   0 0
Total current assets: 634,354 325,983
Creditors: amounts falling due within one year: 7 (4,299,296) (2,558,303)
Net current assets (liabilities): (3,664,942) (2,232,320)
Total assets less current liabilities: 1,989,797 2,646,577
Creditors: amounts falling due after more than one year: 8 (1,825,278) (146,025)
Provision for liabilities: 0 0
Total net assets (liabilities): 164,519 2,500,552
Capital and reserves
Called up share capital: 1,185 1,185
Share premium account: 7,994,323 7,994,323
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: (7,830,989) (5,494,956)
Shareholders funds: 164,519 2,500,552

The notes form part of these financial statements

PHYTOME RESEARCH LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 02 October 2025
and signed on behalf of the board by:

Name: Robert Mark Braddon Parnall
Status: Director

The notes form part of these financial statements

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

Turnover policy

The Company's turnover was derived from the provision of contract research and consultancy services. Management has reviewed each contract and has recognised revenue at the point at which the relevant services were completed and accepted by the customer and in accordance with the project milestones set out in the contracts.

Tangible fixed assets and depreciation policy

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases. Freehold property 5 to 30 years Plant and Machinery 5 years Laboratory and Equipment 4 to 30 years Fixtures and Fittings 8 years Computer Equipment 3 years Freehold land is not depreciated. Assets under construction are not depreciated until such time as the asset is completed and put into use. Certain individual assets within the asset categories shown above may be depreciated using shorter or longer rates depending on the asset concerned.

Intangible fixed assets and amortisation policy

The Company’s intangible asset at the balance sheet date represents costs directly attributable to the application for a Home Office licence for controlled drugs, which was activated on 6 June 2022. The licence is central to the Company's operations and subject to annual renewal, in addition to which the Company will be subject to inspection by the Home Office every 3 to 5 years. There are otherwise no legal, regulatory, contractual, competitive, economic, or other factors limiting its useful life. The Board of Directors have therefore concluded the intangible asset has an indefinite useful life. As such, the intangible asset will not be amortised but will be subject to annual impairment testing.

Valuation and information policy

Work in progress relates to unbilled work carried out in respect of contract research and consultancy services

Other accounting policies

Significant judgements and estimations The preparation of financial statements requires the Company’s management to make judgments, estimates and assumptions that affect the application of accounting policies and reported amounts of assets, liabilities, revenues and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised and in any future periods affected. Significant areas requiring the use of estimates include the carrying values of the tangible fixed assets, intangible assets together with the useful economic lives of the tangible fixed assets. Further details are provided in the relevant notes. Actual results could differ from those estimates. Judgments made by management include the factors used to determine their assessment of whether the going concern assumption is appropriate. The assessment of the going concern assumption requires management to take into account all available information about the future, which is at least, but is not limited to, 12 months from the end of the reporting period. The Company is aware that material uncertainties related to events or conditions may cast significant doubt upon the Company’s ability to continue as a going concern. Financial Instruments The Company has elected to apply the provisions of Section 11 Basic Financial Instruments and Section 12 Other Financial Instruments Issues of FRS 102 to all of its financial instruments. Financial instruments are recognised in the Company's balance sheet when the Company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Classification of financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial liabilities Basic financial liabilities, including creditors, bank loans and other loans loans that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Equity instruments Equity instruments issued by the Company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. Foreign Currencies Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit. Taxation Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates and tax laws that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively. Impairment of non financial assets At the end of each reporting period, the Company’s non financial assets are reviewed to determine whether there is any indication that those assets may be impaired. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment, if any. The recoverable amount is the higher of fair value less costs to sell and value in use. Fair value is determined as the amount that would be obtained from the sale of the asset in an arm’s length transaction between knowledgeable and willing parties. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount and the impairment loss is recognised in profit or loss for the year. For an asset that does not generate largely independent cash flows, the recoverable amount is determined for the cash generating unit to which the asset belongs. A cash generating unit is the smallest group of assets for which there are separate identifiable cash flows. Where an impairment loss subsequently reverses, the carrying amount of the asset or cash generating unit is increased to the revised estimate of its recoverable amount, but to an amount that does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset or cash generating unit in prior years. A reversal of an impairment loss is recognised immediately in profit or loss. An impairment loss recognised with respect to goodwill cannot be subsequently reversed. Borrowing costs Borrowings are recognised initially at fair value, net of transaction costs incurred. Borrowings are subsequently carried at amortised cost any difference between the proceeds net of transaction costs and the redemption value is recognised in profit or loss over the period of the borrowings, using the effective interest method. Fees paid on the establishment of loan facilities are recognised as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. To the extent that there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalised as a prepayment for liquidity services, and amortised over the period of the facility to which it relates. General and specific borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 12 18

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Intangible Assets

Total
Cost £
At 01 January 2024 204,486
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 December 2024 204,486
Amortisation
At 01 January 2024 0
Charge for year 0
On disposals 0
Other adjustments 0
At 31 December 2024 0
Net book value
At 31 December 2024 204,486
At 31 December 2023 204,486

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Tangible Assets

Total
Cost £
At 01 January 2024 5,114,458
Additions 1,051,073
Disposals 0
Revaluations 0
Transfers 0
At 31 December 2024 6,165,531
Depreciation
At 01 January 2024 440,047
Charge for year 275,232
On disposals 0
Other adjustments 0
At 31 December 2024 715,279
Net book value
At 31 December 2024 5,450,252
At 31 December 2023 4,674,411

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

5. Fixed investments

Investment in subsidiary Investment in subsidiary is recorded at cost, which is the fair value of the consideration given, less impairment. The subsidiary, Phytome Nutraceuticals Limited, has share capital consisting of one £1 ordinary share wholly owned by the Company. Phytome Nuraceuticals Limited is dormant, registered in England and Wales, with a registered office at 15 to 19 Westgate Street, Launceston, Cornwall, PL15 7AB.

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

6. Debtors

2024 2023
££
Debtors due after more than one year: 0 0

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

7. Creditors: amounts falling due within one year note

Trade creditors 307805 Other loans 3353531 Other creditors 637960 Total creditors 4299296. In July 2025 the Company repaid all of its short term loans included in other loans above. At the same time the Company took out a new loan of 3.8 million including interest and arrangement fees which will fall due on 25 January 2026. The loan is secured against the Company's freehold land and property.

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

8. Creditors: amounts falling due after more than one year note

Other loans from Parent Company £1825278

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

9. Loans to directors

Name of director receiving advance or credit: Povl Sebastian Hansen Vaughan
Description of the loan: At the balance sheet date, a loan was outstanding of £96,826 from Povl Vaughan, a director of the Company in respect of unpaid share options.
£
Balance at 01 January 2024 96,826
Advances or credits made: 0
Advances or credits repaid: 0
Balance at 31 December 2024 96,826

PHYTOME RESEARCH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

10. Related party transactions

Name of the related party: Controlled Extracts Limited
Relationship:
Client
Description of the Transaction: Consultancy Services
£
Balance at 01 January 2024 55,896
Balance at 31 December 2024 56,526
Name of the related party: Trelonk Limited
Relationship:
Service Provider
Description of the Transaction: Services received
£
Balance at 01 January 2024 0
Balance at 31 December 2024 210
Name of the related party: Trelonk Limited
Relationship:
Supplier
Description of the Transaction: Services received
£
Balance at 01 January 2024 938
Balance at 31 December 2024 0
Name of the related party: Parnall Property Services Limited
Relationship:
Service Provider
Description of the Transaction: Services received
£
Balance at 01 January 2024 19,333
Balance at 31 December 2024 0
Name of the related party: Parnall Group Limited
Relationship:
Supplier
Description of the Transaction: Services received
£
Balance at 01 January 2024 0
Balance at 31 December 2024 0
Name of the related party: Parnalls Solicitors Limited
Relationship:
Supplier
Description of the Transaction: Services received
£
Balance at 01 January 2024 0
Balance at 31 December 2024 0
Name of the related party: Tides Reach Limited
Relationship:
Supplier
Description of the Transaction: Services received
£
Balance at 01 January 2024 0
Balance at 31 December 2024 0